O
ncology is ever more patient-centric, and the American College of Surgeons Commission on Cancer (CoC) is setting standards to that end.
The organization, which has been accrediting oncology clinics since 1933, has expanded its focus beyond oncology and treatment standards to include several complementary supportive-care programs designed to enhance a patient's cancer experience. These new standards include risk assessment and genetic counseling, palliative care services, the patient navigation process, psychosocial distress screening, and survivorship care. For accreditation, institutions must enforce the standards by 2015.
The CoC accredits about one-quarter of all institutions offering cancer care in the United States, but those 1,500 centers treat some 70% of all newly diagnosed patients, according to the commission.
Although a hospital's decision to apply for accreditation is voluntary, the CoC seal of approval connotes quality cancer care, said Stephen B. Edge, M.D., CoC chair and Alfiero Foundation endowed chair in breast oncology and professor of surgery and oncology at Roswell Park Cancer Institute in New York.
Modernizing Oncology
According to Daniel P. McKellar, M.D., chair of the CoC accreditation committee and medical director at Wayne HealthCare in Greenville, Ohio, the new standards were in part prompted by certain Institute of Medicine reports that had criticized oncology care. The CoC considers the standards part of modern oncology. "It's not an easy thing to address the entire continuum of care, but we wanted to make sure that the new standards had a direct patient benefit, and we invited certain advocacy and patient organizations to join us so that all perspectives would be included," McKellar said.
He said that the CoC is the main organization in the country with any power to make cancer centers make changes in cancer care, and although the new programs do not have to be implemented until 2015, the educational process has already begun. "This is a tremendous open door to educate health care professionals, and an opportunity for patients to get every component of care since the commission will be looking over the shoulders of cancer programs to make sure patients are getting that care," McKellar said.
According to Edge, CoC-accredited institutions will have to increase accrual to clinical trials by 2015, but accrual benchmarks will be based on the hospital's size. For example, community hospitals, which did not have an accrual requirement before, will have to recruit 2% of their patients for trials but will also get credit for referring their patients to other institutions. And accrual in academic cancer centers will increase from 2% to 4%, but they will also receive additional commendations if they recruit a higher percentage.
The new standards add to existing ones, which include the following:
• Meeting all CoC standards and specified thresholds on quality improvement measures
• Maintaining a database of cancer cases treated at the facility that must be submitted annually to CoC's National Cancer Database
• Performing internal quality improvement assessments
• Undergoing an external assessment every 3 years
• Performing annual prevention and screening activities designed to meet specific community needs
• Ensuring that all processes are in place to meet all the needs of cancer patients
• Diagnosing and treating cancer according to national guidelines
The largest cancer data repository in the world, CoC's National Cancer Database "has evolved from just being a repository for retrospective analysis to a prospective mechanism for evaluation, m o n i t o r i n g , and tracking of quality," Edge said.
Through a now-voluntary Rapid Quality Reporting System, hospitals enter data about every patient and then transmit them to the College of Surgeons headquarters in Chicago, which tracks whether patients' care is meeting the standards.
"Then the clock is ticking by diagnosis and if, for instance, it doesn't state that a certain patient has started chemotherapy by a certain time, then an alert goes out saying that certain measures may not have taken place," Edge said.
Noting that the CoC accredits institutions, not individuals, and that private practices deliver much of cancer care, he added The CoC standards for psychosocial distress are an amazingly helpful nudge, said Holland, who is founding president of both the American Psychosocial Oncology Society and the International Psycho-Oncology Society and is generally regarded as the founder of psycho-oncology.
"Nobody ever before has come to someone like me and asked, 'What do we have to do to make sure we don't lose our accreditation?' So instilling a little fear, the stick, is going to be helpful to us because when there is no stick and there is no reimbursement to speak of, it is hard to get anyone to move, so I think this is going to be a helpful thing," she said.
Holland added that the new standards incorporate three points: (1) distress screening as the standard of care for oncology patients; (2) development and implementation of a process to integrate and monitor on-site psychosocial distress screening and referral; and (3) He added that the standards may help patients overcome obstacles to getting complete care. "I'm avoiding using the phrase 'being more compliant,'" he continued, "since [we should not be] blaming patients for the fact that they were unable to get complete treatment-when the reality is, sometimes there are a lot of social issues that are beyond the patients' control that prevent them from getting complete treatment."
